Farsin Yadegardjam
Chairman at GENEART AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Wolfgang Schlumberger | M | - |
EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | - |
Claus Kremoser | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | 22 years |
Harald Haberkorn | M | - |
EVP Capital Management AG
EVP Capital Management AG Investment ManagersFinance EVP Capital Management AG (EVP) is the venture capital arm of Switzerland-based Co-Investor AG. Formerly known as equinet Venture Partners, the firm was formally established in 1998 and is located in Frankfurt. EVP manages venture capital funds including the EAP Start-Fonds sponsored by the government-controlled KfW Bankengruppe, and the VRP fund (Venture Capital Rheinland-Pfalz) sponsored by the regional development agency ISB-Investitions- und Strukturbank Rheinland-Pfalz and by the regional bank Landesbank Rheinland-Pfalz, as well as by leading insurance companies and corporations. EVP is also active in the secondary market. In 2004 the firm took over the management of Heptagon Capital Beteiligungsgesellschaft der Freien Sparkassen mbH on behalf of the seven independent German savings banks.
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 13 years |
Bernd Merkl | M | - |
GENEART AG
GENEART AG Miscellaneous Commercial ServicesCommercial Services GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany. | 19 years |
Marcus Graf | M | - |
GENEART AG
GENEART AG Miscellaneous Commercial ServicesCommercial Services GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany. | 25 years |
Julian Kohl | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 8 years |
Thomas Hoffmann | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Jürgen Kaden | M | - |
EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | - |
André Schouten | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 14 years |
Christoph Hendrickx | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 6 years |
Florian Fischer | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 6 years |
Harald Poth | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Andreas Victor Ziegler | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Vincent Imbos | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Torsten Hollstein | M | 59 |
K & K Group AG
K & K Group AG MiscellaneousMiscellaneous K & K Group AG operates as a holding Swiss company. The private company is based in Zug, CH. and has subsidiaries in Switzerland, United Kingdom and Germany. | - |
Amard Jean | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Patricia Martinez-Merello Diaz | F | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Jon Michot | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Fernando Accioly Menezes | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Klaus Dörner | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Thomas Schlüter | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Moritz Ohlenschlager | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 15 years |
Ralph Eric Kunz | M | 57 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 6 years |
Nicolai von Engelhardt | M | 62 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 15 years |
Anja Trespe | M | - |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 24 years |
Karoline Stürmer | M | - |
GENEART AG
GENEART AG Miscellaneous Commercial ServicesCommercial Services GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany. | - |
Ingo Köhler | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Bertram Gilka-Bötzow | M | - |
GENEART AG
GENEART AG Miscellaneous Commercial ServicesCommercial Services GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany. | - |
Mathias Albert Boehringer | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Daniel Schaetti | M | - |
SDP Holding NV
SDP Holding NV Financial ConglomeratesFinance Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018. | - |
Karlheinz Schmelig | M | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | - |
Hans Wolf | M | - |
GENEART AG
GENEART AG Miscellaneous Commercial ServicesCommercial Services GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany. | - |
Dirk Beecker | M | 58 |
EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hans-Dieter Rompel | M | 76 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 14 years |
Thomas Hoch | M | 57 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.
EVP Capital Management AG
EVP Capital Management AG Investment ManagersFinance EVP Capital Management AG (EVP) is the venture capital arm of Switzerland-based Co-Investor AG. Formerly known as equinet Venture Partners, the firm was formally established in 1998 and is located in Frankfurt. EVP manages venture capital funds including the EAP Start-Fonds sponsored by the government-controlled KfW Bankengruppe, and the VRP fund (Venture Capital Rheinland-Pfalz) sponsored by the regional development agency ISB-Investitions- und Strukturbank Rheinland-Pfalz and by the regional bank Landesbank Rheinland-Pfalz, as well as by leading insurance companies and corporations. EVP is also active in the secondary market. In 2004 the firm took over the management of Heptagon Capital Beteiligungsgesellschaft der Freien Sparkassen mbH on behalf of the seven independent German savings banks. | 20 years |
Jörg Becker | M | 55 |
Technische Universität Darmstadt
| 5 years |
Bernd W. Matthes | M | 64 |
Technische Universität Darmstadt
| 6 years |
Michael Teifel | M | - |
Technische Universität Darmstadt
| 3 years |
Dirk Schäfer | M | - |
Technische Universität Darmstadt
| 4 years |
Gernot Berger | M | - |
Technische Universität Darmstadt
| 7 years |
Peter Emanuel Merck | M | - |
Technische Universität Darmstadt
| 1 years |
Klaus Wolfgang Paulini | M | 60 |
Technische Universität Darmstadt
| 3 years |
Martin Fahrendorf | M | 59 |
Technische Universität Darmstadt
| 6 years |
Britta Giesen | M | 58 |
Technische Universität Darmstadt
| 3 years |
Pu Chen | M | 62 |
Technische Universität Darmstadt
| 5 years |
Ingo Bollhöfer | M | 54 |
Technische Universität Darmstadt
| 4 years |
Frank Schepp | M | 54 |
Technische Universität Darmstadt
| 5 years |
Heiko Arnold | M | 58 |
Technische Universität Darmstadt
| 3 years |
Matthias T. Pfeiffer | M | - |
Technische Universität Darmstadt
| 3 years |
Roland Leuenberger | M | 56 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | 1 years |
Jutta A. Dönges | M | 51 |
Technische Universität Darmstadt
| 5 years |
Bernd Schulte | M | 62 |
Technische Universität Darmstadt
| 3 years |
Thorsten Claus | M | - |
Technische Universität Darmstadt
| 7 years |
Stephan Itter | M | - |
Technische Universität Darmstadt
| 7 years |
Jan Christoph Teetz | M | - |
Technische Universität Darmstadt
| 5 years |
Konstantin Alfred Winterstein | M | 55 |
Technische Universität Darmstadt
| 4 years |
Claudia Perlich | M | - |
Technische Universität Darmstadt
| 6 years |
Wolfgang Winter | M | 57 |
Technische Universität Darmstadt
| 4 years |
Dominik Wlodarczak | M | 60 |
COI Partners AG
COI Partners AG Investment ManagersFinance COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich. | - |
Karl-Josef Junglas | M | 69 |
Technische Universität Darmstadt
| 3 years |
Barbara Jakubeit | F | - |
Technische Universität Darmstadt
| 1 years |
Umut Apaydin | M | - |
Technische Universität Darmstadt
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 43 | 69.35% |
Switzerland | 14 | 22.58% |
Belgium | 7 | 11.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Farsin Yadegardjam
- Personal Network